Stabilized pharmaceutical
Patent 5763493 Issued on June 9, 1998. Estimated Expiration Date: 
June 21, 2016. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
June 21, 2016. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References Re33994 3819706 3885046 Compounds and methods of making same Compounds and methods of making them Compounds and methods of making Prolactin suppression in mammals 3H Labeled compounds Radioactive nuclide labeled propiophenone compounds Bupropion radioimmunoassay, and kit InventorsApplicationNo. 667239 filed on 06/21/1996US Classes:514/617R contains benzene ringExaminersPrimary: Cintins, Marianne M.Assistant: Jones, Dwayne C. Attorney, Agent or FirmForeign Patent References
International ClassesA01N 037/18A61K 031/165 Foreign Application Priority Data1993-07-30 GBAbstractThis application discloses a method of inhibiting degradation of the antidepressant bupropion hydrochloride in a solid pharmaceutical formulation, so that the pharmaceutical formulation will maintain at least 80% of its initial bupropion potency after one year.Other References
Field of SearchR contains benzene ring | |
